This idea is supported by the findings that, like TGF-β, p21 has been reported to be increased in different experimental models of glomerular diseases such as membranous nephropathy (PHN model) [229], streptozotocin-induced diabetic nephropathy [230], and minimal change nephropathy. The gene discussed is TGFB1; the disease is diabetic kidney disease.